关注
Raniya Khadiullina
Raniya Khadiullina
在 kpfu.ru 的电子邮件经过验证
标题
引用次数
引用次数
年份
Proteomic analysis of human serum from patients with chronic kidney disease
Y Romanova, A Laikov, M Markelova, R Khadiullina, A Makseev, ...
Biomolecules 10 (2), 257, 2020
502020
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
R Mirgayazova, R Khadiullina, V Chasov, R Mingaleeva, R Miftakhova, ...
Genes 11 (6), 704, 2020
472020
Key players in the mutant p53 team: Small molecules, gene editing, immunotherapy
V Chasov, R Mirgayazova, E Zmievskaya, R Khadiullina, A Valiullina, ...
Frontiers in Oncology 10, 1460, 2020
382020
Discovery of nanomolar-affinity pharmacological chaperones stabilizing the oncogenic p53 mutant Y220C
JR Stephenson Clarke, LR Douglas, PJ Duriez, DI Balourdas, AC Joerger, ...
ACS pharmacology & translational science 5 (11), 1169-1180, 2022
322022
Promising new tools for targeting p53 mutant cancers: Humoral and cell-based immunotherapies
V Chasov, M Zaripov, R Mirgayazova, R Khadiullina, E Zmievskaya, ...
Frontiers in Immunology 12, 707734, 2021
302021
Novel Isatin-based activator of p53 transcriptional functions in tumor cells
R Mirgayazova, R Khadiullina, R Mingaleeva, V Chasov, M Gomzikova, ...
Molecular Biology Research Communications 8 (3), 119, 2019
252019
Assessment of thermal stability of mutant p53 proteins via differential scanning fluorimetry
R Khadiullina, R Mirgayazova, D Davletshin, E Khusainova, V Chasov, ...
Life 13 (1), 31, 2022
122022
Anticancer therapeutic strategies for targeting mutant p53-Y220C
V Chasov, D Davletshin, E Gilyazova, R Mirgayazova, A Kudriaeva, ...
Journal of Biomedical Research 38 (3), 222, 2024
2024
130P Restoration of the mutant p53 protein upon treatment with small molecule modulators
E Gilyazova, D Davletshin, R Khadiullina, R Mirgayazova, V Chasov, ...
ESMO Open 8 (1), 2023
2023
Reactivation of tumor suppressor p53 by aminobenzothiazole derivatives
R Khadiullina, D Davletshin, E Khusainova, R Mirgayazova, V Chasov, ...
CELL DEATH DISCOVERY 8, 9-9, 2022
2022
Reaktivatsiya mutantnogo onkosupressora R53 proizvodnymi aminobenzotiazola
RR Khadiullina, DR Davletshin, EM Khusainova, RM Mirgayazova, ...
Genes & Cells 17 (3), 244-244, 2022
2022
78P Small molecule compounds targeting the p53 mutants
R Khadiullina, R Mirgayazova, D Davletshin, E Khusainova, V Chasov, ...
Annals of Oncology 33, S1407, 2022
2022
76P Modulation of mutant p53 activity using indazole derivatives
D Davletshin, E Khusainova, R Khadiullina, R Mirgayazova, M Baud, ...
Annals of Oncology 33, S1406-S1407, 2022
2022
77P Targeted compounds for modulation of mutant p53 activity
E Khusainova, D Davletshin, R Khadiullina, V Chasov, R Mirgayazova, ...
Annals of Oncology 33, S1407, 2022
2022
Activation of Mutant Tumor Suppressor p53 Under the Influence of Small Molecule Modulators
E Khusainova, D Davletshin, R Khadiullina, R Mirgayazova, V Chasov, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022
2022
Novel Small molecules with capability to reactivate mutant p53
E Khusainova, R Khadiullina, D Davletshin, R Mirgayazova, V Chasov, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022
2022
Functional restoration of mutant p53 using targeted small molecule reactivators
R Khadiullina, R Mirgayazova, V Chasov, JS Clarke, A Rizvanov, M Baud, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 51, 130-130, 2021
2021
Application of CRISPR/Cas9 gene editing to obtain cell lines with various TP53 status
R Mirgayazova, R Khadiullina, V Chasov, A Rizvanov, M Baud, E Bulatov
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 51, 130-131, 2021
2021
GENERATING TP53 MUTANT MCF7 CELL LINE WITH CRISPR/CAS9: CELL MODEL FOR TARGETED THERAPIES
RM Mirgayazova, RR Khadiullina, RN Mingaleeva, M Baud, AA Rizvanov, ...
THE INTERNATIONAL CONFERENCE «MOLECULAR MECHANISMS OF AUTOPHAGY IN DISEASES», 30, 2020
2020
Restoring impaired functions of mutant tumor suppressor p53 using synthetic modulators
RR Khadiullina, RM Mirgayazova, RN Mingaleeva, VV Chasov, M Baud, ...
CELL DEATH DISCOVERY 6 (1), 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20